RESEARCH-USE BIOSIMILAR ANTIBODY
Ecromeximab
Monoclonal antibody · IgG1
Ecromeximab (KM 871; KW 2871) is a mouse-derived IgG-κ chimeric antibody targeting ganglioside GD3. Ecromeximab is expressed by YB2/0 rat hybridoma cells.
TARGETGanglioside GD3
YMonoclonal antibody
TARGETGD3
CATALOG NUMBERSC-BS-596
MOLECULAR WEIGHTApprox. 145.26 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ecromeximab (KM 871; KW 2871) is a mouse-derived IgG-κ chimeric antibody targeting ganglioside GD3. Ecromeximab is expressed by YB2/0 rat hybridoma cells.
Ecromeximab is a recombinant research-use antibody directed against Ganglioside GD3 / GD3.